FRINK Linked Data Fragments server

Matches in SemOpenAlex for { <https://semopenalex.org/work/W4315703330> ?p ?o ?g. }

• W4315703330 endingPage "e304" @default.
• W4315703330 startingPage "e304" @default.
• W4315703330 abstract "Background: Hypertension is the most prevalent chronic disease worldwide and is related to a high probability of cardiac disease, kidney disease and cerebrovascular events. Blood pressure measurement was used in the last decades to diagnose and guide antihypertensive therapy; however blood pressure is the result of the interaction of more complex hemodynamic parameters previously reserved for experimental studies or critical care patients management using invasive methods. Since 1996 few studies have proposed the use of hemodynamic parameters to classify and guide hypertension therapy with good results. Purpose: The present study's purpose was to measure hemodynamic parameters in patients with non-controlled resistant hypertension and use it to guide pharmacologic treatment to archive control blood pressure values according to the European Society of Cardiology guidelines. Methods: A total of 84 patients between 32 and 95 years old diagnosed with non-controlled primary resistant hypertension were recruited and after previous therapy washout hemodynamic parameters were measured using noninvasive Methods: preload by central venous pressure (CVP) using inferior vena cava diameter, cardiac index and systemic vascular resistance using Lyljestrand & Zander modified formula. Patients were classified into 3 basic groups depending on which parameter was above normal value: hyperdynamic (HD) for high cardiac index > 3.5 L/min/m2, fluid overload (FO) for CVP > 8cmH2O and high systemic vascular resistance index (HSVRi) > 2500 dynes/sec/m2/cm5, also 3 combined groups were a patient had 2 simultaneous hemodynamic alterations (HD+FO, HD+HSVRi and FO+HSRVi), according to this classification pharmacotherapy was guided indicating Bisoprolol in HD group, Amlodipine to HSVR patients and Hydrochlorothiazide to FO patients, in combined groups, combined therapy was given. Patients were observed for 6 months period taking as primary endpoint blood pressure control, acute cardiovascular events and hypotension. Results: A significant reduction of hemodynamic parameters and blood pressure was observed in the first month of treatment obtaining a 100% hemodynamic and blood pressure goals in all patients in the third month of therapy without hypotension or acute cardiovascular event during this period, the HD+FO group reach goals at the 6th month of treatment without reported complications. Conclusions: In this preliminary study we observed that hemodynamic guided high blood pressure control may be a valuable tool for a better understanding, classification and treatment in patients with resistant hypertension; however larger outcome studies confirm this hypothesis." @default.
• W4315703330 created "2023-01-12" @default.
• W4315703330 creator A5046951498 @default.
• W4315703330 creator A5068154989 @default.
• W4315703330 creator A5091089564 @default.
• W4315703330 date "2023-01-01" @default.
• W4315703330 modified "2023-10-02" @default.
• W4315703330 title "PS-BPC05-7: HEMODYNAMIC MANAGEMENT OF RESISTANT HYPERTENSION" @default.
• W4315703330 doi "https://doi.org/10.1097/01.hjh.0000915840.99471.fc" @default.
• W4315703330 hasPublicationYear "2023" @default.
• W4315703330 type Work @default.
• W4315703330 citedByCount "0" @default.
• W4315703330 crossrefType "journal-article" @default.
• W4315703330 hasAuthorship W4315703330A5046951498 @default.
• W4315703330 hasAuthorship W4315703330A5068154989 @default.
• W4315703330 hasAuthorship W4315703330A5091089564 @default.
• W4315703330 hasBestOaLocation W43157033301 @default.
• W4315703330 hasConcept C126322002 @default.
• W4315703330 hasConcept C139940330 @default.
• W4315703330 hasConcept C164705383 @default.
• W4315703330 hasConcept C178853913 @default.
• W4315703330 hasConcept C2777953023 @default.
• W4315703330 hasConcept C2779646130 @default.
• W4315703330 hasConcept C31861589 @default.
• W4315703330 hasConcept C35207712 @default.
• W4315703330 hasConcept C42219234 @default.
• W4315703330 hasConcept C48277249 @default.
• W4315703330 hasConcept C58245268 @default.
• W4315703330 hasConcept C71924100 @default.
• W4315703330 hasConcept C84393581 @default.
• W4315703330 hasConceptScore W4315703330C126322002 @default.
• W4315703330 hasConceptScore W4315703330C139940330 @default.
• W4315703330 hasConceptScore W4315703330C164705383 @default.
• W4315703330 hasConceptScore W4315703330C178853913 @default.
• W4315703330 hasConceptScore W4315703330C2777953023 @default.
• W4315703330 hasConceptScore W4315703330C2779646130 @default.
• W4315703330 hasConceptScore W4315703330C31861589 @default.
• W4315703330 hasConceptScore W4315703330C35207712 @default.
• W4315703330 hasConceptScore W4315703330C42219234 @default.
• W4315703330 hasConceptScore W4315703330C48277249 @default.
• W4315703330 hasConceptScore W4315703330C58245268 @default.
• W4315703330 hasConceptScore W4315703330C71924100 @default.
• W4315703330 hasConceptScore W4315703330C84393581 @default.
• W4315703330 hasIssue "Suppl 1" @default.
• W4315703330 hasLocation W43157033301 @default.
• W4315703330 hasLocation W43157033302 @default.
• W4315703330 hasOpenAccess W4315703330 @default.
• W4315703330 hasPrimaryLocation W43157033301 @default.
• W4315703330 hasRelatedWork W144401523 @default.
• W4315703330 hasRelatedWork W181897886 @default.
• W4315703330 hasRelatedWork W1976071169 @default.
• W4315703330 hasRelatedWork W1977774560 @default.
• W4315703330 hasRelatedWork W2328985354 @default.
• W4315703330 hasRelatedWork W2438491553 @default.
• W4315703330 hasRelatedWork W2439882859 @default.
• W4315703330 hasRelatedWork W2475327391 @default.
• W4315703330 hasRelatedWork W4244744128 @default.
• W4315703330 hasRelatedWork W4250230600 @default.
• W4315703330 hasVolume "41" @default.
• W4315703330 isParatext "false" @default.
• W4315703330 isRetracted "false" @default.
• W4315703330 workType "article" @default.